Abstract
The potential of the combined use of ESI–QqTOF-MS and ESI–QqTOF-MS/MS with mass-spectral library search for the identification of therapeutic and illicit drugs has been evaluated. Reserpine was used for standardizing experimental conditions and for characterization of the performance of the applied mass spectrometric system. Experiments revealed that because of the mass accuracy, the stability of calibration, and the reproducibility of fragmentation, the QqTOF mass spectrometer is an appropriate platform for establishment of a tandem-mass-spectral library. Three-hundred and nineteen substances were used as reference samples to build the spectral library. For each reference compound, product-ion spectra were acquired at ten different collision-energy values between 5 eV and 50 eV. For identification of unknown compounds, a library search algorithm was developed. The closeness of matching between a measured product-ion spectrum and a spectrum stored in the library was characterized by a value called “match probability”, which took into account the number of matched fragment ions, the number of fragment ions observed in the two spectra, and the sum of the intensity differences calculated for matching fragments. A large value for the match probability indicated a close match between the measured and the reference spectrum. A unique feature of the library search algorithm—an implemented spectral purification option—enables characterization of multi-contributor fragment-ion spectra. With the aid of this software feature, substances comprising only 1.0% of the total amount of binary mixtures were unequivocally assigned, in addition to the isobaric main contributors. The spectral library was successfully applied to the characterization of 39 forensic casework samples.
Similar content being viewed by others
References
Maurer HH (1998) J Chromatogr B 713:3–25
Marquet P (2002) Ther Drug Monit 24:125–133
Rivier L (2003) Anal Chim Acta 492:69–82
Marquet P, Lachatre G (1999) J Chromatogr B 733:93–118
Bogusz MJ (2000) J Chromatogr B 748:3–19
Niessen WM (2003) J Chromatogr A 1000:413–436
Smyth WF, Brooks P (2004) Electrophoresis 25:1413–1446
Maurer HH (2005) Anal Bioanal Chem 381:110–118
Bristow AW (2006) Mass Spectrom Rev 25:99–111
Chernushevich IV, Loboda AV, Thomson BA (2001) J Mass Spectrom 36:849–865
Hernandez F, Ibanez M, Sancho JV, Pozo OJ (2004) Anal Chem 76:4349–4357
Thurman EM, Ferrer I, Fernandez-Alba AR (2005) J Chromatogr A 1067:127–134
Gergov M, Boucher B, Ojanpera I, Vuori E (2001) Rapid Commun Mass Spectrom 15:521–526
Nielen MW, Vissers JP, Fuchs RE, van Velde JW, Lommen A (2001) Rapid Commun Mass Spectrom 15:1577–1585
Zhang H, Heinig K, Henion J (2000) J Mass Spectrom 35:423–431
Pelander A, Ojanpera I, Laks S, Rasanen I, Vuori E (2003) Anal Chem 75:5710–5718
Laks S, Pelander A, Vuori E, Ali-Tolppa E, Sippola E, Ojanpera I (2004) Anal Chem 76:7375–7379
Hopfgartner G, Vilbois F (2000) Analusis 28:906–914
Mortishire-Smith RJ, O’Connor D, Castro-Perez JM, Kirby J (2005) Rapid Commun Mass Spectrom 19:2659–2670
Shukla AK, Futrell JH (2000) J Mass Spectrom 35:1069–1090
Sleno L, Volmer DA (2004) J Mass Spectrom 39:1091–1112
Gabelica V, De Pauw E (2005) Mass Spectrom Rev 24:566–587
Bogusz MJ, Maier RD, Kruger KD, Webb KS, Romeril J, Miller ML (1999) J Chromatogr A 844:409–418
Bristow AW, Nichols WF, Webb KS, Conway B (2002) Rapid Commun Mass Spectrom 16:2374–2386
Gergov M, Weinmann W, Meriluoto J, Uusitalo J, Ojanpera I (2004) Rapid Commun Mass Spectrom 18:1039–1046
Weinmann W, Stoertzel M, Vogt S, Svoboda M, Schreiber A (2001) J Mass Spectrom 36:1013–1023
Josephs JL, Sanders M (2004) Rapid Commun Mass Spectrom 18:743–759
Weinmann W, Gergov M, Goerner M (2000) Analusis 28:934–941
Jansen R, Lachatre G, Marquet P (2005) Clin Biochem 38:362–372
Milman BL (2005) Trends Anal Chem 24:493–508
Lips AG, Lameijer W, Fokkens RH, Nibbering NM (2001) J Chromatogr B 759:191–207
Pihlainen K, Sippola E, Kostiainen R (2003) J Chromatogr A 994:93–102
Rittner M, Pragst F, Bork WR, Neumann J (2001) J Anal Toxicol 25:115–124
Schreiber A, Efer J, Engewald W (2000) J Chromatogr A 869:411–425
Venisse N, Marquet P, Duchoslav E, Dupuy JL, Lachatre G (2003) J Anal Toxicol 27:7–14
Weinmann W, Wiedemann A, Eppinger B, Renz M, Svoboda M (1999) J Am Soc Mass Spectrom 10:1028–1037
Slobodnik J, Hogenboom AC, Vreuls JJ, Rontree JA, van Baar BLM, Niessen WM, Brinkman UA (1996) J Chromatogr A 741:59–74
Kratzsch C, Peters FT, Kraemer T, Weber AA, Maurer HH (2003) J Mass Spectrom 38:283–295
Decaestecker TN, Vande C Sr, Wallemacq PE, Van Peteghem CH, Defore DL, Van Bocxlaer JF (2004) Anal Chem 76:6365–6373
Balogh MP (2004) LC–GC Europe 17:352–359
Stolker AAM, Stephany RW, van Ginkel LA (2000) Analusis 28:947–951
Dudley E, Tuytten R, Bond A, Lemiere F, Brenton AG, Esmans EL, Newton RP (2005) Rapid Commun Mass Spectrom 19:3075–3085
Marquet P, Venisse N, Lachatre G (2000) Analusis 28:925–934
Acknowledgment
The authors wish to thank Applied Biosystems for the generous provision of the mass spectrometer and the associated equipment.
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Below is the link to the electronic supplementary material
Rights and permissions
About this article
Cite this article
Pavlic, M., Libiseller, K. & Oberacher, H. Combined use of ESI–QqTOF-MS and ESI–QqTOF-MS/MS with mass-spectral library search for qualitative analysis of drugs. Anal Bioanal Chem 386, 69–82 (2006). https://doi.org/10.1007/s00216-006-0634-8
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00216-006-0634-8